Brain type I but not type II IL-1 receptors mediate the effects of IL-1β on behavior in mice

被引:32
作者
Cremona, S
Goujon, E
Kelley, KW
Dantzer, R
Parnet, P
机构
[1] INSERM, U394, F-33077 Bordeaux, France
[2] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA
关键词
antibodies; social exploration; mouse;
D O I
10.1152/ajpregu.1998.274.3.R735
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
In the immune system, interleukin (IL)-1 beta effects are mediated by the type I IL-1 receptors (IL-1RI), whereas the type II IL-1 receptors (IL-1RII) act as inhibitory receptors. IL-1RI and IL-1RII are also present in the brain. To study their functionality in the brain, mice were centrally treated with neutralizing monoclonal antibody (MAb) directed against IL-1RI (35F5, 1 mu g) or against IL-1RII (4E2, 2 mu g) and were centrally injected with recombinant rat IL-1 beta at a dose (2 ng) that decreased social exploration. Only 35F5 was effective in abrogating the behavioral effect of IL-1 beta. Moreover, 4E2 (1 mu g icv) did not potentiate the behavioral response to a subthreshold dose of IL-1 beta (1 ng icv). To examine the ability of brain IL-1RI to mediate the effects of endogenous IL-1 beta, mice were centrally treated with 35F5 (4 mu g) and peripherally injected with IL-1 beta (1 mu g). Like IL-1 receptor antagonist (4 mu g icy), 35F5 abrogated the effects of IL-1 beta. These results suggest that brain IL-1RI mediates the behavioral effects of IL-1 beta in mice.
引用
收藏
页码:R735 / R740
页数:6
相关论文
共 30 条
  • [1] INTERLEUKIN-1 RECEPTOR ANTAGONIST - A NEW MEMBER OF THE INTERLEUKIN-1 FAMILY
    AREND, WP
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1991, 88 (05) : 1445 - 1451
  • [2] BENVENISTE EN, 1992, NEUROIMMUNOENDOCRINO, P106
  • [3] BOSSU P, 1995, AM J PATHOL, V147, P1852
  • [4] 2 HIGH-AFFINITY INTERLEUKIN-1 RECEPTORS REPRESENT SEPARATE GENE-PRODUCTS
    CHIZZONITE, R
    TRUITT, T
    KILIAN, PL
    STERN, AS
    NUNES, P
    PARKER, KP
    KAFFKA, KL
    CHUA, AO
    LUGG, DK
    GUBLER, U
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (20) : 8029 - 8033
  • [5] THE TYPE-II DECOY RECEPTOR - A NOVEL REGULATORY PATHWAY FOR INTERLEUKIN-1
    COLOTTA, F
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    [J]. IMMUNOLOGY TODAY, 1994, 15 (12): : 562 - 566
  • [6] INTERLEUKIN-1 TYPE-II RECEPTOR - A DECOY TARGET FOR IL-1 THAT IS REGULATED BY IL-4
    COLOTTA, F
    RE, F
    MUZIO, M
    BERTINI, R
    POLENTARUTTI, N
    SIRONI, M
    GIRI, JG
    DOWER, SK
    SIMS, JE
    MANTOVANI, A
    [J]. SCIENCE, 1993, 261 (5120) : 472 - 475
  • [7] CUNNINGHAM ET, 1992, J NEUROSCI, V12, P1101
  • [8] DINARELLO CA, 1994, EUR CYTOKINE NETW, V5, P517
  • [9] DINARELLO CA, 1992, INFLAMMATION BASIC P, P211
  • [10] MONOCLONAL-ANTIBODY 1994-01 (ALSO KNOWN AS ALVA-42) REPORTED TO RECOGNIZE TYPE-II IL-1 RECEPTOR IS SPECIFIC FOR HLA-DR ALPHA-CHAIN AND BETA-CHAIN
    GAYLE, MA
    SIMS, JE
    DOWER, SK
    SLACK, JL
    [J]. CYTOKINE, 1994, 6 (01) : 83 - 86